• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    24.95 Down 0.67(2.62%) Jun 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:25.62
    Open:25.87
    Bid:24.51 x 100
    Ask:27.80 x 2000
    1y Target Est:30.73
    Beta:1.2
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:24.61 - 25.99
    52wk Range:11.33 - 35.23
    Volume:1,010,495
    Avg Vol (3m):1,369,430
    Market Cap:1.03B
    P/E (ttm):N/A
    EPS (ttm):-4.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SRPTDown 2.62%1.03B
    ALNYUp 0.09%11.06B
    GSKDown 0.50%106.62B
    ISISDown 0.56%8.01B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):289.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.88
    Quarterly EPS Est (Jun-15) :-1.22
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):25.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback